The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente

NCT01066650 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1391

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Angina Pectoris
Unstable Angina Pectoris
Coronary Stenosis
Coronary Restenosis

Interventions

DEVICE: Endeavor Resolute (Biolinx-based Zotarolimus-eluting stent)
DEVICE: Xience V (Everolimus-eluting stent)

Sponsor

Foundation of Cardiovascular Research and Education Enschede